AMG 479 in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors

Clinical trial NCT01024387 · COMPLETED

Trial details

NCT number: NCT01024387
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Neuroendocrine Tumor Carcinoid Tumor Pancreatic Neuroendocrine Tumor

Start date: 2010-03-01
Primary completion: 2016-01-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.